Pairnomix is a health care and pharmaceutical startup with a mission to utilize genetic insights and innovative treatment options for rare disease discovery and development. Established in January 2016, Pairnomix provides support to physicians and patients by offering detailed information about rare genetic mutations and suitable drug therapies. The company's specialized genetic research involves creating a model of a patient’s genetic mutation, examining its functional impacts, and testing approved drugs on the model to identify new treatment options. The results are then presented in personalized reports to the patient’s physician, facilitating better-informed healthcare decisions. Moreover, Pairnomix's insights contribute to rare disease drug discovery and development efforts, ultimately aiming to empower personalized healthcare.
There is no investment information
No recent news or press coverage available for Pairnomix.